John Castle
Chief Tech/Sci/R&D Officer at MONTE ROSA THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Schiff | M | 58 | 4 years | |
| Markus Warmuth | M | 53 | 4 years | |
| Sharon Townson | M | 49 | 4 years | |
| Kimberly Blackwell | M | 55 | 4 years | |
| Iraj Ali | M | 48 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 years |
| Sierk Poetting | M | 51 | 10 years | |
| Ulf Arne Wiinberg | M | 66 | 8 years | |
| Jennifer Champoux | F | - | 3 years | |
| Jan Skvarka | M | 57 | 1 years | |
| Anthony Manning | M | 62 | 1 years | |
| Ali Behbahani | M | 45 | 4 years | |
| Chandra Paul Leo | M | 53 | 4 years | |
| Christine Siu | F | 47 | 4 years | |
| Alfred Dadson | M | - | 8 years | |
| Sean Marett | M | 59 | 12 years | |
| Filip Janku | M | 50 | 3 years | |
| Philip Nickson | M | 45 | 3 years | |
| Michael Rapé | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shalini Sharp | F | 49 | 15 years | |
| Karen Valentine | F | 52 | 14 years | |
| Allison Jeynes-Ellis | M | 58 | 6 years | |
| Jean-Marie Cuillerot | M | - | 2 years | |
| Christian Cortis | M | - | - | |
| Mohammed Malik | M | 56 | 3 years | |
| Michael Kring | M | 52 | 5 years | |
| Ozer Baysal | M | 68 | - | |
| Tom Dechaene | M | 65 | 16 years | |
| Alexander Mayweg | M | 49 | 6 years | |
| Donald Vidic | M | - | 2 years | |
| Owen Wallace | M | 55 | 3 years | |
| Paulo Moreira | M | - | 2 years | |
| Anna Wijatyk | M | - | - | |
| Sunil Gupta | M | - | - | |
| Michael Plater | M | - | 1 years | |
| Charles Ballantyne | M | 64 | 1 years | |
| James Gorman | M | - | - | |
| Min Wang | M | - | 1 years | |
| Jane Robertson | M | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 4 years |
| Ernest Shingyan Wong | M | 56 | - | |
| Jullian Jones | M | - | - | |
| Marc van Dijk | M | 61 | - | |
| Ajim Tamboli | M | 47 | 3 years | |
| Alexander Duncan | M | 62 | 5 years | |
| Justin Zelin | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 39 | 88.64% |
| Germany | 3 | 6.82% |
| United Kingdom | 2 | 4.55% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Castle
- Personal Network
